Fig. 1 · Structure
Documents & Downloads
Fenoldopam mesylate
D1 Receptor Agonist
Fenoldopam mesylate is a selective D1 receptor agonist known for its multifaceted biological activities. It demonstrates notable antihypertensive effects and exhibits inhibitory action on lysine-specific demethylase 1 (LSD1) with an IC50 of 0.8974 μM. Additionally, Fenoldopam mesylate has been shown to inhibit cancer cell proliferation and induce apoptosis in various cell lines, making it a valuable tool for research in cardiovascular and oncology studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 67227-57-0 |
| Applications | D1 Receptor Agonist |
| Formula | C17H20ClNO6S |
| Molecular Weight | 401.86 |
| Synonyms | Fenoldopam methanesulfonate; SKF-82526 mesylate |
| SMILES | OC1=C(O)C=C2C(C3=CC=C(O)C=C3)CNCCC2=C1Cl.CS(=O)(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.